The Nuclear Medicine Radioisotopes market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Nuclear Medicine Radioisotopes market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Nuclear Medicine Radioisotopes market. The report focuses on well-known providers in the global Nuclear Medicine Radioisotopes industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Nuclear Medicine Radioisotopes Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Nuclear Medicine Radioisotopes market covered in Chapter 4:
Positron Corporation
Siemens Healthcare
NTP Radioisotopes SOC Ltd
Hologic Inc.
Agfa-Gevaert N.V.
Cardiarc Ltd
Cardinal Health Inc.
Bracco S.p.A
CMR Naviscan (Gamma Medica Inc.)
Naviscan Inc
Gamma Medica Inc
Segami Corporation
Medx Inc
Curium
Nordion (Canada) Inc.
Ge Healthcare
Digirad Corporation

In Chapter 11 and 13.3, on the basis of types, the Nuclear Medicine Radioisotopes market from 2015 to 2026 is primarily split into:
Rubidium-82 (Rb-82)
Actinium-225 (Ac-225)
Radium-223 (Ra-223) & Alpharadin
Technetium-99m (Tc-99m)
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Iodine-131 (I-131)
Lutetium-177 (Lu-177)
Others

In Chapter 12 and 13.4, on the basis of applications, the Nuclear Medicine Radioisotopes market from 2015 to 2026 covers:
Oncology
Cardiology
Lymphoma
Thyroid
Neurology
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Nuclear Medicine Radioisotopes Market Share by Type (2020-2026)
1.5.2 Rubidium-82 (Rb-82)
1.5.3 Actinium-225 (Ac-225)
1.5.4 Radium-223 (Ra-223) & Alpharadin
1.5.5 Technetium-99m (Tc-99m)
1.5.6 Thallium-201 (Tl-201)
1.5.7 Iodine (I-123)
1.5.8 Fluorine-18
1.5.9 Iodine-131 (I-131)
1.5.10 Lutetium-177 (Lu-177)
1.5.11 Others
1.6 Market by Application
1.6.1 Global Nuclear Medicine Radioisotopes Market Share by Application (2020-2026)
1.6.2 Oncology
1.6.3 Cardiology
1.6.4 Lymphoma
1.6.5 Thyroid
1.6.6 Neurology
1.6.7 Others
1.7 Nuclear Medicine Radioisotopes Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Nuclear Medicine Radioisotopes Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Nuclear Medicine Radioisotopes Market
3.1 Value Chain Status
3.2 Nuclear Medicine Radioisotopes Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Nuclear Medicine Radioisotopes
3.2.3 Labor Cost of Nuclear Medicine Radioisotopes
3.2.3.1 Labor Cost of Nuclear Medicine Radioisotopes Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 Positron Corporation
4.1.1 Positron Corporation Basic Information
4.1.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.1.3 Positron Corporation Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.1.4 Positron Corporation Business Overview
4.2 Siemens Healthcare
4.2.1 Siemens Healthcare Basic Information
4.2.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.2.3 Siemens Healthcare Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.2.4 Siemens Healthcare Business Overview
4.3 NTP Radioisotopes SOC Ltd
4.3.1 NTP Radioisotopes SOC Ltd Basic Information
4.3.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.3.3 NTP Radioisotopes SOC Ltd Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.3.4 NTP Radioisotopes SOC Ltd Business Overview
4.4 Hologic Inc.
4.4.1 Hologic Inc. Basic Information
4.4.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.4.3 Hologic Inc. Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.4.4 Hologic Inc. Business Overview
4.5 Agfa-Gevaert N.V.
4.5.1 Agfa-Gevaert N.V. Basic Information
4.5.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.5.3 Agfa-Gevaert N.V. Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.5.4 Agfa-Gevaert N.V. Business Overview
4.6 Cardiarc Ltd
4.6.1 Cardiarc Ltd Basic Information
4.6.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.6.3 Cardiarc Ltd Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.6.4 Cardiarc Ltd Business Overview
4.7 Cardinal Health Inc.
4.7.1 Cardinal Health Inc. Basic Information
4.7.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.7.3 Cardinal Health Inc. Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.7.4 Cardinal Health Inc. Business Overview
4.8 Bracco S.p.A
4.8.1 Bracco S.p.A Basic Information
4.8.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.8.3 Bracco S.p.A Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.8.4 Bracco S.p.A Business Overview
4.9 CMR Naviscan (Gamma Medica Inc.)
4.9.1 CMR Naviscan (Gamma Medica Inc.) Basic Information
4.9.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.9.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.9.4 CMR Naviscan (Gamma Medica Inc.) Business Overview
4.10 Naviscan Inc
4.10.1 Naviscan Inc Basic Information
4.10.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.10.3 Naviscan Inc Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.10.4 Naviscan Inc Business Overview
4.11 Gamma Medica Inc
4.11.1 Gamma Medica Inc Basic Information
4.11.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.11.3 Gamma Medica Inc Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.11.4 Gamma Medica Inc Business Overview
4.12 Segami Corporation
4.12.1 Segami Corporation Basic Information
4.12.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.12.3 Segami Corporation Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.12.4 Segami Corporation Business Overview
4.13 Medx Inc
4.13.1 Medx Inc Basic Information
4.13.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.13.3 Medx Inc Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.13.4 Medx Inc Business Overview
4.14 Curium
4.14.1 Curium Basic Information
4.14.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.14.3 Curium Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.14.4 Curium Business Overview
4.15 Nordion (Canada) Inc.
4.15.1 Nordion (Canada) Inc. Basic Information
4.15.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.15.3 Nordion (Canada) Inc. Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.15.4 Nordion (Canada) Inc. Business Overview
4.16 Ge Healthcare
4.16.1 Ge Healthcare Basic Information
4.16.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.16.3 Ge Healthcare Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.16.4 Ge Healthcare Business Overview
4.17 Digirad Corporation
4.17.1 Digirad Corporation Basic Information
4.17.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
4.17.3 Digirad Corporation Nuclear Medicine Radioisotopes Market Performance (2015-2020)
4.17.4 Digirad Corporation Business Overview

5 Global Nuclear Medicine Radioisotopes Market Analysis by Regions
5.1 Global Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Regions
5.1.1 Global Nuclear Medicine Radioisotopes Sales by Regions (2015-2020)
5.1.2 Global Nuclear Medicine Radioisotopes Revenue by Regions (2015-2020)
5.2 North America Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
5.3 Europe Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
5.6 South America Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)

6 North America Nuclear Medicine Radioisotopes Market Analysis by Countries
6.1 North America Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Countries
6.1.1 North America Nuclear Medicine Radioisotopes Sales by Countries (2015-2020)
6.1.2 North America Nuclear Medicine Radioisotopes Revenue by Countries (2015-2020)
6.1.3 North America Nuclear Medicine Radioisotopes Market Under COVID-19
6.2 United States Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
6.2.1 United States Nuclear Medicine Radioisotopes Market Under COVID-19
6.3 Canada Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
6.4 Mexico Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)

7 Europe Nuclear Medicine Radioisotopes Market Analysis by Countries
7.1 Europe Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Countries
7.1.1 Europe Nuclear Medicine Radioisotopes Sales by Countries (2015-2020)
7.1.2 Europe Nuclear Medicine Radioisotopes Revenue by Countries (2015-2020)
7.1.3 Europe Nuclear Medicine Radioisotopes Market Under COVID-19
7.2 Germany Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
7.2.1 Germany Nuclear Medicine Radioisotopes Market Under COVID-19
7.3 UK Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
7.3.1 UK Nuclear Medicine Radioisotopes Market Under COVID-19
7.4 France Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
7.4.1 France Nuclear Medicine Radioisotopes Market Under COVID-19
7.5 Italy Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
7.5.1 Italy Nuclear Medicine Radioisotopes Market Under COVID-19
7.6 Spain Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
7.6.1 Spain Nuclear Medicine Radioisotopes Market Under COVID-19
7.7 Russia Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
7.7.1 Russia Nuclear Medicine Radioisotopes Market Under COVID-19

8 Asia-Pacific Nuclear Medicine Radioisotopes Market Analysis by Countries
8.1 Asia-Pacific Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Nuclear Medicine Radioisotopes Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Nuclear Medicine Radioisotopes Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Nuclear Medicine Radioisotopes Market Under COVID-19
8.2 China Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
8.2.1 China Nuclear Medicine Radioisotopes Market Under COVID-19
8.3 Japan Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
8.3.1 Japan Nuclear Medicine Radioisotopes Market Under COVID-19
8.4 South Korea Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
8.4.1 South Korea Nuclear Medicine Radioisotopes Market Under COVID-19
8.5 Australia Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
8.6 India Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
8.6.1 India Nuclear Medicine Radioisotopes Market Under COVID-19
8.7 Southeast Asia Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Nuclear Medicine Radioisotopes Market Under COVID-19

9 Middle East and Africa Nuclear Medicine Radioisotopes Market Analysis by Countries
9.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Nuclear Medicine Radioisotopes Market Under COVID-19
9.2 Saudi Arabia Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
9.3 UAE Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
9.4 Egypt Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
9.5 Nigeria Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
9.6 South Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)

10 South America Nuclear Medicine Radioisotopes Market Analysis by Countries
10.1 South America Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Countries
10.1.1 South America Nuclear Medicine Radioisotopes Sales by Countries (2015-2020)
10.1.2 South America Nuclear Medicine Radioisotopes Revenue by Countries (2015-2020)
10.1.3 South America Nuclear Medicine Radioisotopes Market Under COVID-19
10.2 Brazil Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
10.2.1 Brazil Nuclear Medicine Radioisotopes Market Under COVID-19
10.3 Argentina Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
10.4 Columbia Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
10.5 Chile Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)

11 Global Nuclear Medicine Radioisotopes Market Segment by Types
11.1 Global Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Nuclear Medicine Radioisotopes Sales and Market Share by Types (2015-2020)
11.1.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Types (2015-2020)
11.2 Rubidium-82 (Rb-82) Sales and Price (2015-2020)
11.3 Actinium-225 (Ac-225) Sales and Price (2015-2020)
11.4 Radium-223 (Ra-223) & Alpharadin Sales and Price (2015-2020)
11.5 Technetium-99m (Tc-99m) Sales and Price (2015-2020)
11.6 Thallium-201 (Tl-201) Sales and Price (2015-2020)
11.7 Iodine (I-123) Sales and Price (2015-2020)
11.8 Fluorine-18 Sales and Price (2015-2020)
11.9 Iodine-131 (I-131) Sales and Price (2015-2020)
11.10 Lutetium-177 (Lu-177) Sales and Price (2015-2020)
11.11 Others Sales and Price (2015-2020)

12 Global Nuclear Medicine Radioisotopes Market Segment by Applications
12.1 Global Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Nuclear Medicine Radioisotopes Sales and Market Share by Applications (2015-2020)
12.1.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Applications (2015-2020)
12.2 Oncology Sales, Revenue and Growth Rate (2015-2020)
12.3 Cardiology Sales, Revenue and Growth Rate (2015-2020)
12.4 Lymphoma Sales, Revenue and Growth Rate (2015-2020)
12.5 Thyroid Sales, Revenue and Growth Rate (2015-2020)
12.6 Neurology Sales, Revenue and Growth Rate (2015-2020)
12.7 Others Sales, Revenue and Growth Rate (2015-2020)

13 Nuclear Medicine Radioisotopes Market Forecast by Regions (2020-2026)
13.1 Global Nuclear Medicine Radioisotopes Sales, Revenue and Growth Rate (2020-2026)
13.2 Nuclear Medicine Radioisotopes Market Forecast by Regions (2020-2026)
13.2.1 North America Nuclear Medicine Radioisotopes Market Forecast (2020-2026)
13.2.2 Europe Nuclear Medicine Radioisotopes Market Forecast (2020-2026)
13.2.3 Asia-Pacific Nuclear Medicine Radioisotopes Market Forecast (2020-2026)
13.2.4 Middle East and Africa Nuclear Medicine Radioisotopes Market Forecast (2020-2026)
13.2.5 South America Nuclear Medicine Radioisotopes Market Forecast (2020-2026)
13.3 Nuclear Medicine Radioisotopes Market Forecast by Types (2020-2026)
13.4 Nuclear Medicine Radioisotopes Market Forecast by Applications (2020-2026)
13.5 Nuclear Medicine Radioisotopes Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source

List of Tables and Figures
Table Global Nuclear Medicine Radioisotopes Market Size Growth Rate by Type (2020-2026)
Figure Global Nuclear Medicine Radioisotopes Market Share by Type in 2019 & 2026
Figure Rubidium-82 (Rb-82) Features
Figure Actinium-225 (Ac-225) Features
Figure Radium-223 (Ra-223) & Alpharadin Features
Figure Technetium-99m (Tc-99m) Features
Figure Thallium-201 (Tl-201) Features
Figure Iodine (I-123) Features
Figure Fluorine-18 Features
Figure Iodine-131 (I-131) Features
Figure Lutetium-177 (Lu-177) Features
Figure Others Features
Table Global Nuclear Medicine Radioisotopes Market Size Growth by Application (2020-2026)
Figure Global Nuclear Medicine Radioisotopes Market Share by Application in 2019 & 2026
Figure Oncology Description
Figure Cardiology Description
Figure Lymphoma Description
Figure Thyroid Description
Figure Neurology Description
Figure Others Description
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Nuclear Medicine Radioisotopes Industry Development
Table SWOT Analysis
Figure Porter's Five Forces Analysis
Figure Global Nuclear Medicine Radioisotopes Market Size and Growth Rate 2015-2026
Table Industry News
Table Industry Policies
Figure Value Chain Status of Nuclear Medicine Radioisotopes
Figure Production Process of Nuclear Medicine Radioisotopes
Figure Manufacturing Cost Structure of Nuclear Medicine Radioisotopes
Figure Major Company Analysis (by Business Distribution Base, by Product Type)
Table Downstream Major Customer Analysis (by Region)
Table Positron Corporation Profile
Table Positron Corporation Production, Value, Price, Gross Margin 2015-2020
Table Siemens Healthcare Profile
Table Siemens Healthcare Production, Value, Price, Gross Margin 2015-2020
Table NTP Radioisotopes SOC Ltd Profile
Table NTP Radioisotopes SOC Ltd Production, Value, Price, Gross Margin 2015-2020
Table Hologic Inc. Profile
Table Hologic Inc. Production, Value, Price, Gross Margin 2015-2020
Table Agfa-Gevaert N.V. Profile
Table Agfa-Gevaert N.V. Production, Value, Price, Gross Margin 2015-2020
Table Cardiarc Ltd Profile
Table Cardiarc Ltd Production, Value, Price, Gross Margin 2015-2020
Table Cardinal Health Inc. Profile
Table Cardinal Health Inc. Production, Value, Price, Gross Margin 2015-2020
Table Bracco S.p.A Profile
Table Bracco S.p.A Production, Value, Price, Gross Margin 2015-2020
Table CMR Naviscan (Gamma Medica Inc.) Profile
Table CMR Naviscan (Gamma Medica Inc.) Production, Value, Price, Gross Margin 2015-2020
Table Naviscan Inc Profile
Table Naviscan Inc Production, Value, Price, Gross Margin 2015-2020
Table Gamma Medica Inc Profile
Table Gamma Medica Inc Production, Value, Price, Gross Margin 2015-2020
Table Segami Corporation Profile
Table Segami Corporation Production, Value, Price, Gross Margin 2015-2020
Table Medx Inc Profile
Table Medx Inc Production, Value, Price, Gross Margin 2015-2020
Table Curium Profile
Table Curium Production, Value, Price, Gross Margin 2015-2020
Table Nordion (Canada) Inc. Profile
Table Nordion (Canada) Inc. Production, Value, Price, Gross Margin 2015-2020
Table Ge Healthcare Profile
Table Ge Healthcare Production, Value, Price, Gross Margin 2015-2020
Table Digirad Corporation Profile
Table Digirad Corporation Production, Value, Price, Gross Margin 2015-2020
Figure Global Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Global Nuclear Medicine Radioisotopes Revenue ($) and Growth (2015-2020)
Table Global Nuclear Medicine Radioisotopes Sales by Regions (2015-2020)
Table Global Nuclear Medicine Radioisotopes Sales Market Share by Regions (2015-2020)
Table Global Nuclear Medicine Radioisotopes Revenue ($) by Regions (2015-2020)
Table Global Nuclear Medicine Radioisotopes Revenue Market Share by Regions (2015-2020)
Table Global Nuclear Medicine Radioisotopes Revenue Market Share by Regions in 2015
Table Global Nuclear Medicine Radioisotopes Revenue Market Share by Regions in 2019
Figure North America Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure South America Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure North America Nuclear Medicine Radioisotopes Revenue ($) and Growth (2015-2020)
Table North America Nuclear Medicine Radioisotopes Sales by Countries (2015-2020)
Table North America Nuclear Medicine Radioisotopes Sales Market Share by Countries (2015-2020)
Figure North America Nuclear Medicine Radioisotopes Sales Market Share by Countries in 2015
Figure North America Nuclear Medicine Radioisotopes Sales Market Share by Countries in 2019
Table North America Nuclear Medicine Radioisotopes Revenue ($) by Countries (2015-2020)
Table North America Nuclear Medicine Radioisotopes Revenue Market Share by Countries (2015-2020)
Figure North America Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2015
Figure North America Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2019
Figure United States Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Canada Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Mexico Nuclear Medicine Radioisotopes Sales and Growth (2015-2020)
Figure Europe Nuclear Medicine Radioisotopes Revenue ($) Growth (2015-2020)
Table Europe Nuclear Medicine Radioisotopes Sales by Countries (2015-2020)
Table Europe Nuclear Medicine Radioisotopes Sales Market Share by Countries (2015-2020)
Figure Europe Nuclear Medicine Radioisotopes Sales Market Share by Countries in 2015
Figure Europe Nuclear Medicine Radioisotopes Sales Market Share by Countries in 2019
Table Europe Nuclear Medicine Radioisotopes Revenue ($) by Countries (2015-2020)
Table Europe Nuclear Medicine Radioisotopes Revenue Market Share by Countries (2015-2020)
Figure Europe Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2015
Figure Europe Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2019
Figure Germany Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure UK Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure France Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Italy Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Spain Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Russia Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine Radioisotopes Revenue ($) and Growth (2015-2020)
Table Asia-Pacific Nuclear Medicine Radioisotopes Sales by Countries (2015-2020)
Table Asia-Pacific Nuclear Medicine Radioisotopes Sales Market Share by Countries (2015-2020)
Figure Asia-Pacific Nuclear Medicine Radioisotopes Sales Market Share by Countries in 2015
Figure Asia-Pacific Nuclear Medicine Radioisotopes Sales Market Share by Countries in 2019
Table Asia-Pacific Nuclear Medicine Radioisotopes Revenue ($) by Countries (2015-2020)
Table Asia-Pacific Nuclear Medicine Radioisotopes Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2015
Figure Asia-Pacific Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2019
Figure China Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Japan Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure South Korea Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Australia Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure India Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Southeast Asia Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine Radioisotopes Revenue ($) and Growth (2015-2020)
Table Middle East and Africa Nuclear Medicine Radioisotopes Sales by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine Radioisotopes Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine Radioisotopes Revenue ($) by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine Radioisotopes Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2015
Figure Middle East and Africa Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2019
Figure Saudi Arabia Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure UAE Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Egypt Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Nigeria Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure South Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure South America Nuclear Medicine Radioisotopes Revenue ($) and Growth (2015-2020)
Table South America Nuclear Medicine Radioisotopes Sales by Countries (2015-2020)
Table South America Nuclear Medicine Radioisotopes Sales Market Share by Countries (2015-2020)
Table South America Nuclear Medicine Radioisotopes Revenue ($) by Countries (2015-2020)
Table South America Nuclear Medicine Radioisotopes Revenue Market Share by Countries (2015-2020)
Figure South America Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2015
Figure South America Nuclear Medicine Radioisotopes Revenue Market Share by Countries in 2019
Figure Brazil Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Argentina Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Columbia Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Figure Chile Nuclear Medicine Radioisotopes Sales and Growth Rate (2015-2020)
Table Global Nuclear Medicine Radioisotopes Sales by Types (2015-2020)
Table Global Nuclear Medicine Radioisotopes Sales Share by Types (2015-2020)
Table Global Nuclear Medicine Radioisotopes Revenue ($) by Types (2015-2020)
Table Global Nuclear Medicine Radioisotopes Revenue Share by Types (2015-2020)
Figure Global Rubidium-82 (Rb-82) Sales and Growth Rate (2015-2020)
Figure Global Rubidium-82 (Rb-82) Price (2015-2020)
Figure Global Actinium-225 (Ac-225) Sales and Growth Rate (2015-2020)
Figure Global Actinium-225 (Ac-225) Price (2015-2020)
Figure Global Radium-223 (Ra-223) & Alpharadin Sales and Growth Rate (2015-2020)
Figure Global Radium-223 (Ra-223) & Alpharadin Price (2015-2020)
Figure Global Technetium-99m (Tc-99m) Sales and Growth Rate (2015-2020)
Figure Global Technetium-99m (Tc-99m) Price (2015-2020)
Figure Global Thallium-201 (Tl-201) Sales and Growth Rate (2015-2020)
Figure Global Thallium-201 (Tl-201) Price (2015-2020)
Figure Global Iodine (I-123) Sales and Growth Rate (2015-2020)
Figure Global Iodine (I-123) Price (2015-2020)
Figure Global Fluorine-18 Sales and Growth Rate (2015-2020)
Figure Global Fluorine-18 Price (2015-2020)
Figure Global Iodine-131 (I-131) Sales and Growth Rate (2015-2020)
Figure Global Iodine-131 (I-131) Price (2015-2020)
Figure Global Lutetium-177 (Lu-177) Sales and Growth Rate (2015-2020)
Figure Global Lutetium-177 (Lu-177) Price (2015-2020)
Figure Global Others Sales and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Nuclear Medicine Radioisotopes Sales by Applications (2015-2020)
Table Global Nuclear Medicine Radioisotopes Sales Share by Applications (2015-2020)
Figure Global Oncology Sales and Growth Rate (2015-2020)
Figure Global Oncology Revenue and Growth Rate (2015-2020)
Figure Global Cardiology Sales and Growth Rate (2015-2020)
Figure Global Cardiology Revenue and Growth Rate (2015-2020)
Figure Global Lymphoma Sales and Growth Rate (2015-2020)
Figure Global Lymphoma Revenue and Growth Rate (2015-2020)
Figure Global Thyroid Sales and Growth Rate (2015-2020)
Figure Global Thyroid Revenue and Growth Rate (2015-2020)
Figure Global Neurology Sales and Growth Rate (2015-2020)
Figure Global Neurology Revenue and Growth Rate (2015-2020)
Figure Global Others Sales and Growth Rate (2015-2020)
Figure Global Others Revenue and Growth Rate (2015-2020)
Figure Global Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2026)
Figure Global Nuclear Medicine Radioisotopes Revenue ($) and Growth Rate (2020-2026)
Table Global Nuclear Medicine Radioisotopes Sales Forecast by Regions (2020-2026)
Table Global Nuclear Medicine Radioisotopes Revenue Forecast by Regions (2020-2026)
Figure North America Nuclear Medicine Radioisotopes Sales Forecast (2020-2026)
Figure North America Nuclear Medicine Radioisotopes Revenue Forecast (2020-2026)
Figure Europe Nuclear Medicine Radioisotopes Sales Forecast (2020-2026)
Figure Europe Nuclear Medicine Radioisotopes Revenue Forecast (2020-2026)
Figure Asia-Pacific Nuclear Medicine Radioisotopes Sales Forecast (2020-2026)
Figure Asia-Pacific Nuclear Medicine Radioisotopes Revenue Forecast (2020-2026)
Figure Middle East and Africa Nuclear Medicine Radioisotopes Sales Forecast (2020-2026)
Figure Middle East and Africa Nuclear Medicine Radioisotopes Revenue Forecast (2020-2026)
Figure South America Nuclear Medicine Radioisotopes Sales Forecast (2020-2026)
Figure South America Nuclear Medicine Radioisotopes Revenue Forecast (2020-2026)
Table Global Nuclear Medicine Radioisotopes Sales Forecast by Types (2020-2026)
Table Global Nuclear Medicine Radioisotopes Sales Market Share Forecast by Types (2020-2026)
Table Global Nuclear Medicine Radioisotopes Revenue Forecast by Types (2020-2026)
Table Global Nuclear Medicine Radioisotopes Revenue Market Share Forecast by Types (2020-2026)
Table Global Nuclear Medicine Radioisotopes Sales Forecast by Applications (2020-2026)
Table Global Nuclear Medicine Radioisotopes Sales Market Share Forecast by Applications (2020-2026)
Table Global Nuclear Medicine Radioisotopes Revenue Forecast by Applications (2020-2026)
Table Global Nuclear Medicine Radioisotopes Revenue Market Share Forecast by Applications (2020-2026)